
Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis
Author(s) -
J. Eron,
C.-C. Hung,
J.-G. Baril,
J. Slim,
V. Falco,
J. Bogner,
F. Maggiolo,
A. Mills,
J. Sievers,
C.Y. Man,
R. Urbaityte,
M. Underwood,
A.R. Tenorio,
K.A. Pappa,
B. Wynne,
J. Koteff,
M. Gartland,
K.Y. Smith,
M. Aboud
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7m46-x605
Subject(s) - dolutegravir , emtricitabine , tenofovir , lamivudine , virology , medicine , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , virus , hepatitis b virus